KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010

Drug interactions are one of the Drug Related Problems (DRPs) that may affect patient treatment outcomes. Hypertension occurs in approximately 10% to 81.5% of hemodialysis patients. The purpose of this study was to determine the incidence of antihypertensive drug interactions in hemodialysis pati...

Full description

Bibliographic Details
Main Authors: Siti Rahmiati, Woro Supadmi
Format: Article
Language:English
Published: Universitas Ahmad Dahlan 2012-05-01
Series:Pharmaciana
Subjects:
Online Access:http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/658/498
_version_ 1818657654029942784
author Siti Rahmiati
Woro Supadmi
author_facet Siti Rahmiati
Woro Supadmi
author_sort Siti Rahmiati
collection DOAJ
description Drug interactions are one of the Drug Related Problems (DRPs) that may affect patient treatment outcomes. Hypertension occurs in approximately 10% to 81.5% of hemodialysis patients. The purpose of this study was to determine the incidence of antihypertensive drug interactions in hemodialysis patients in the inpatient wards PKU Muhammadiyah Hospital of Yogyakarta period in 2010. This study descriptive design. Data retrieved retrospectively. Data retrieval were done by taking all the data that meet the criteria of existing research on the medical records of hemodialysis patients in PKU Muhammadiyah Hospital of Yogyakarta who received antihypertensive with above normal blood pressure (= 130/80 mmHg). Data were analyzed based on the descriptive level of significance, onset, and severity. The results showed that there were 54.79% (40 patients) of 73 hemodialysis patients potentially experienced drug interactions. Antihypertensive drugs most widely used in hemodialysis patients were ACEI, CCB, and diuretics. Incidence of antihypertensive drug interactions 27 cases (45.76% were most common at a significance level 3, 48 cases (81.36%) were onset delayed, and the severity minor of 44 cases (74.58%). The mechanism of interactions pharmacodynamic were 37 cases (62.71%) of the total 59 events that have drug interactions. Drugs often interactions were furosemide and captopril.
first_indexed 2024-12-17T03:44:54Z
format Article
id doaj.art-f08da721350d4a668f5330a37bae61cd
institution Directory Open Access Journal
issn 2088-4559
2477-0256
language English
last_indexed 2024-12-17T03:44:54Z
publishDate 2012-05-01
publisher Universitas Ahmad Dahlan
record_format Article
series Pharmaciana
spelling doaj.art-f08da721350d4a668f5330a37bae61cd2022-12-21T22:04:55ZengUniversitas Ahmad DahlanPharmaciana2088-45592477-02562012-05-01219711010.12928/pharmaciana.v2i1.658KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010Siti Rahmiati0Woro Supadmi1Universitas Ahmad DahlanUniversitas Ahmad DahlanDrug interactions are one of the Drug Related Problems (DRPs) that may affect patient treatment outcomes. Hypertension occurs in approximately 10% to 81.5% of hemodialysis patients. The purpose of this study was to determine the incidence of antihypertensive drug interactions in hemodialysis patients in the inpatient wards PKU Muhammadiyah Hospital of Yogyakarta period in 2010. This study descriptive design. Data retrieved retrospectively. Data retrieval were done by taking all the data that meet the criteria of existing research on the medical records of hemodialysis patients in PKU Muhammadiyah Hospital of Yogyakarta who received antihypertensive with above normal blood pressure (= 130/80 mmHg). Data were analyzed based on the descriptive level of significance, onset, and severity. The results showed that there were 54.79% (40 patients) of 73 hemodialysis patients potentially experienced drug interactions. Antihypertensive drugs most widely used in hemodialysis patients were ACEI, CCB, and diuretics. Incidence of antihypertensive drug interactions 27 cases (45.76% were most common at a significance level 3, 48 cases (81.36%) were onset delayed, and the severity minor of 44 cases (74.58%). The mechanism of interactions pharmacodynamic were 37 cases (62.71%) of the total 59 events that have drug interactions. Drugs often interactions were furosemide and captopril.http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/658/498drug interactionsantihypertensivehemodialysis
spellingShingle Siti Rahmiati
Woro Supadmi
KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010
Pharmaciana
drug interactions
antihypertensive
hemodialysis
title KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010
title_full KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010
title_fullStr KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010
title_full_unstemmed KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010
title_short KAJIAN INTERAKSI OBAT ANTIHIPERTENSI PADA PASIEN HEMODIALISIS DI BANGSAL RAWAT INAP RSU PKU MUHAMMADIYAH YOGYAKARTA PERIODE TAHUN 2010
title_sort kajian interaksi obat antihipertensi pada pasien hemodialisis di bangsal rawat inap rsu pku muhammadiyah yogyakarta periode tahun 2010
topic drug interactions
antihypertensive
hemodialysis
url http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/658/498
work_keys_str_mv AT sitirahmiati kajianinteraksiobatantihipertensipadapasienhemodialisisdibangsalrawatinaprsupkumuhammadiyahyogyakartaperiodetahun2010
AT worosupadmi kajianinteraksiobatantihipertensipadapasienhemodialisisdibangsalrawatinaprsupkumuhammadiyahyogyakartaperiodetahun2010